论文期刊

取消

高级检索

检索历史清除

首页> Molecules (Basel, Switzerland)> Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.

Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.

导出 OA

翻译打印收藏纠错

作者： Ricardo G,Alvim ^[1] ; Petrina,Georgala ^[2] ; Lucas,Nogueira ^[3] ; Alexander J,Somma ^[1] ; Karan,Nagar ^[2] ; Jasmine,Thomas ^[1] ; Laura,Alvim ^[1] ; Amelia,Riegel ^[1] ; Christopher,Hughes ^[1] ; Jie,Chen ^[1] ; Augusto B,Reis ^[1] ; Souhil,Lebdai ^[1] ; Avigdor,Scherz ^[4] ; Steven,Zanganeh ^[1] ; Rui,Gardner ^[2] ; Kwanghee,Kim ^[5] ; Jonathan A,Coleman ^[6]

作者单位： Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. ^[1] Department of Surgery, Federal University of Minas Gerais, Belo Horizonte 30130-100, Brazil ^[2] Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. ^[3] Department of Plants and Environmental Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel ^[4] Department of Bioengineering, University of Massachusetts, Dartmouth, MA 02747, USA. ^[5] Flow Cytometry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. ^[6]

关键词 TOOKAD bladder cancer focal therapy immunotherapy tumor ablation

主题词动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);疾病模型, 动物(Disease Models, Animal);人类(Humans);免疫(Immunity);免疫疗法(Immunotherapy);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);光化学疗法(Photochemotherapy);受体, OX40(Receptors, OX40);T淋巴细胞(T-Lymphocytes);泌尿系肿瘤(Urologic Neoplasms);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.3390/molecules26123744

PMID 34205347

发布时间 2022-03-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecules (Basel, Switzerland)

Molecules (Basel, Switzerland)

2021年26卷12期

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷